Treos Bio's Unattributed Round

Treos Bio raised a round of funding on February 13, 2017.

Treos uses cancer vaccine technology to develop precision cancer immunotherapies. These therapies are peptide vaccines that induce potent immune responses to kill the specific cancer cells in patients…

Articles about Treos Bio's Unattributed Round: